BridgeBio Pharma GAAP EPS of -$1.00 misses by $0.33, revenue of $154.2M beats by $5.13M

BridgeBio Pharma's GAAP EPS of -$1.00 missed estimates by $0.33, though its revenue of $154.2 million beat by $5.13 million.